Previous 10 | Next 10 |
Solution seamlessly delivers proprietary technology, real world data and analytics, aligning to industry security and data privacy standards ICON plc , (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announces the release of its next ...
2023-09-13 10:17:32 ET More on ICON ICON: Economic Business Returns Lagging Capital Charge, Revise To Hold ICON in pact with BARDA for next-gen COVID vaccine trial What’s next for clinical research firms after pandemic boom? For further details see: ...
2023-09-13 08:52:47 ET More on Icon Seeking Alpha’s Quant Rating on Icon Historical earnings data for Icon Financial information for Icon ICON: Economic Business Returns Lagging Capital Charge, Revise To Hold ICON Public Limited Company ( I...
ICON plc , (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announces that it is partnering with the U.S. Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the...
ICON plc , (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the Baird Global Healthcare Conference on Wednesday, September 13, 2023 at 10:15 am ET. Any changes to this ev...
2023-08-22 14:52:24 ET More on Regeneron, Johnson & Johnson Regeneron Gets Boost With FDA Approval Of High-Dose Eylea (Rating Upgrade) Johnson & Johnson Vs. Kenvue: The Better Dividend Aristocrat Might Shock You ICON: Economic Business Returns Lagging Capital...
2023-08-16 04:29:58 ET Summary ICON came in with a reasonable set of growth percentages in its Q2 numbers. The acquisition of PRA Health has not added the expected value to ICON I had hoped, potentially dragging down shareholder value. The debate centers around the treatment o...
Shares of ICON Public Limited Company (NASDAQ: ICLR) traded at a new 52-week high today and are currently trading at $261.46. So far today, approximately 18,634 shares have been exchanged, as compared to an average 30-day volume of 794.65k shares. ICON Public Limited Company, a clinical resea...
2023-07-30 07:10:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. Baron Small Cap Fund had a strong performance in Q2 2023, up 6.49% and up 16.54% for t...
2023-07-27 13:23:08 ET ICON Public Limited Company (ICLR) Q2 2023 Earnings Conference Call July 27, 2023, 08:00 ET Company Participants Kate Haven - VP, IR Steven Cutler - CEO & Director Brendan Brennan - CFO Conference Call Participants Alexander...
News, Short Squeeze, Breakout and More Instantly...
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that it will release its financial results for the second quarter 2024 after the market closes on Wednesday, July 24, 2024. The company will hold a conference call and webcas...
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 1:30pm ET. Any changes to this event and links...
2024-05-31 07:00:07 ET David Windley from Jefferies issued a price target of $390.00 for ICLR on 2024-05-31 05:48:00. The adjusted price target was set to $390.00. At the time of the announcement, ICLR was trading at $322.92. The overall price target consensus is at $265...